dividend

Under the repurchase plan, Thermo Fisher is cleared to buy $1 billion of its common stock in both the open market and through negotiated transactions.

NEW YORK (GenomeWeb) – Agilent Technologies said after the close of the market Wednesday that its board of directors has approved the separation of Keysight Technologies, the new name for its electronic measurement subsidiary, from the firm and has named a successor to current CEO Bill Sullivan.

NEW YORK (GenomeWeb News) – Agilent Technologies today said that its board of directors has authorized a new share repurchase program, which will become effective following the completion of its existing $1 billion share repurchase program.

The firm will pay a quarterly dividend of $.19 per share.

The firm will pay a quarterly dividend of $.41 per share.

The firm will pay a quarterly dividend of $.07 per share.

The firm will pay out a quarterly dividend of $.41 per common share.

The firm will pay a dividend of $.07 per share of common stock.

The board approved the quarterly divided of $0.02 per share.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.